https://orcid.org/0000-0001-8748-0083
Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Frank M.C. Besag, Michael J. Vasey & Richard F.M. Chin. (2023) Current and emerging pharmacotherapy for the treatment of Lennox-Gastaut syndrome. Expert Opinion on Pharmacotherapy 24:11, pages 1249-1268.
Read now
Read now
Laveena Singla, Manan Shah, Debra Moore-Hill, Peter Rosenquist & Klepper Alfredo Garcia. (2022) Electroconvulsive therapy for super refractory status epilepticus in pregnancy: case report and review of literature. International Journal of Neuroscience 0:0, pages 1-11.
Read now
Read now
Gaetano Zaccara, Simona Lattanzi, Antonio Leo & Emilio Russo. (2021) Critical Appraisal of Cenobamate as Adjunctive Treatment of Focal Seizures in Adults. Neuropsychiatric Disease and Treatment 17, pages 3447-3457.
Read now
Read now
Articles from other publishers (21)
Soura Challal, Adrianna Skiba, Mélanie Langlois, Camila V. Esguerra, Jean-Luc Wolfender, Alexander D. Crawford & Krystyna Skalicka-Woźniak. (2023) Natural product-derived therapies for treating drug-resistant epilepsies: From ethnopharmacology to evidence-based medicine. Journal of Ethnopharmacology 317, pages 116740.
Crossref
Crossref
Sung Bum Park, Byumseok Koh, Hyun Soo Kwon, Young Eun Kim, Seong Soon Kim, Sung-Hee Cho, Tae-Young Kim, Myung Ae Bae, Dukjin Kang, Chul Hoon Kim & Ki Young Kim. (2023) Quantitative and Qualitative Analysis of Neurotransmitter and Neurosteroid Production in Cerebral Organoids during Differentiation. ACS Chemical Neuroscience 14:20, pages 3761-3771.
Crossref
Crossref
Tafere Mulaw Belete. (2023) Recent Progress in the Development of New Antiepileptic Drugs with Novel Targets. Annals of Neurosciences 30:4, pages 262-276.
Crossref
Crossref
Emilio Perucca, Meir Bialer & H. Steve White. (2023) New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: I. Role of GABA as a Modulator of Seizure Activity and Recently Approved Medications Acting on the GABA System. CNS Drugs 37:9, pages 755-779.
Crossref
Crossref
William L. Fitch, Steven Smith, Michael Saporito, Gregory Busse, Mingbao Zhang, Julie Ren, Michael E. Fitzsimmons, Ping Yi, Stephen English, Adam Carter & Thomas A. Baillie. (2023) Complex Metabolism of the Novel Neurosteroid, Ganaxolone, in Humans: A Unique Challenge for Metabolites in Safety Testing Assessment. Drug Metabolism and Disposition 51:6, pages 753-763.
Crossref
Crossref
Alexander Bryson, Christopher Reid & Steven Petrou. (2023)
Fundamental Neurochemistry Review: GABA
A
receptor neurotransmission and epilepsy: Principles, disease mechanisms and pharmacotherapy
. Journal of Neurochemistry 165:1, pages 6-28.
Crossref
Crossref
Lena-Luise Becker & Angela M. Kaindl. (2023) Corticosteroids in childhood epilepsies: A systematic review. Frontiers in Neurology 14.
Crossref
Crossref
Joseph Sullivan, Boudewijn Gunning, Muhammad Zafar, Renzo Guerrini, Jozef Gecz, Kristy L. Kolc, Yufan Zhao, Maciej Gasior, Alex A. Aimetti & Debopam Samanta. (2023) Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsy. Epilepsy Research 191, pages 107112.
Crossref
Crossref
Susan J. Keam & Zaina T. Al-Salama. (2023) Ganaxolone in seizures associated with cyclin-dependent kinase-like 5 deficiency disorder: a profile of its use in the USA. Drugs & Therapy Perspectives 39:3, pages 81-88.
Crossref
Crossref
Jiahao Meng, Zeya Yan, Xinyu Tao, Wei Wang, Fei Wang, Tao Xue, Yanfei Liu & Zhong Wang. (2022) The efficacy and safety of ganaxolone for the treatment of refractory epilepsy: A meta‐analysis from randomized controlled trials. Epilepsia Open 8:1, pages 90-99.
Crossref
Crossref
Nelufar Yasmen, Madison N. Sluter, Ying Yu & Jianxiong Jiang. (2023) Ganaxolone for management of seizures associated with CDKL5 deficiency disorder. Trends in Pharmacological Sciences 44:2, pages 128-129.
Crossref
Crossref
Shixin Wang, Xin Wu, Tao Xue, Zhaoming Song, Xin Tan, Xiaoou Sun & Zhong Wang. (2023) Efficacy and safety of levetiracetam versus valproate in patients with established status epilepticus: A systematic review and meta-analysis. Heliyon 9:2, pages e13380.
Crossref
Crossref
Aphrodite Chakraborty, Soumil Dey, Krishan Kumar, Aparna B. Dixit, Manjari Tripathi, Mehar C. Sharma, P. Sarat Chandra & Jyotirmoy Banerjee. (2023) Novel variants in GABAA receptor subunits: A possible association with benzodiazepine resistance in patients with drug-resistant epilepsy. Epilepsy Research 189, pages 107056.
Crossref
Crossref
Carla Marini & Maria Giardino. (2021) Novel treatments in epilepsy guided by genetic diagnosis. British Journal of Clinical Pharmacology 88:6, pages 2539-2551.
Crossref
Crossref
Deepak Gill. (2022) A potential new treatment for CDKL5 deficiency disorder. The Lancet Neurology 21:5, pages 394-395.
Crossref
Crossref
Elia M Pestana Knight, Sam Amin, Nadia Bahi-Buisson, Tim A Benke, J Helen Cross, Scott T Demarest, Heather E Olson, Nicola Specchio, Thomas R Fleming, Alex A Aimetti, Maciej Gasior, Orrin Devinsky, Elena Belousova, Oleg Belyaev, Bruria Ben-Zeev, Andreas Brunklaus, Michael A. Ciliberto, Francesca Darra, Ronald Davis, Valentina De Giorgis, Olga Doronina, Michael Fahey, Renzo Guerrini, Peter Heydemann, Olga Khaletskaya, Pawel Lisewski, Eric D. Marsh, Ahsan N. Moosa, Scott Perry, Sunny Philip, Rajsekar R. Rajaraman, Ben Renfroe, Russell P. Saneto, Ingrid E. Scheffer, Yoshimi Sogawa, Bernhardt Suter, Matthew T. Sweney, Daniel Tarquinio, Pierangelo Veggiotti, Geoff Wallace, Judy Weisenberg, Angus Wilfong, Elaine C. Wirrell, Muhammad Zafar & Marta Zolnowska. (2022) Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trial. The Lancet Neurology 21:5, pages 417-427.
Crossref
Crossref
Julia C. Shaw, Rebecca M. Dyson, Hannah K. Palliser, Ryan P. Sixtus, Heather Barnes, Carlton L. Pavy, Gabrielle K. Crombie, Mary J. Berry & Jonathan J. Hirst. (2022) Examining Neurosteroid-Analogue Therapy in the Preterm Neonate For Promoting Hippocampal Neurodevelopment. Frontiers in Physiology 13.
Crossref
Crossref
Dominique Q. Perez, Adrian I. Espiritu & Roland Dominic G. Jamora. (2022) Perampanel in achieving status epilepticus cessation: A systematic review. Epilepsy & Behavior 128, pages 108583.
Crossref
Crossref
Rani K. Singh, Rajdeep Singh, Alejandra Stewart, Katherine Van Poppel, Sarah Klinger, Joseph Hulihan, Heather Van Heusen, Henrikas Vaitkevicius & Maciej Gasior. (2022) Intravenous ganaxolone in pediatric super-refractory status epilepticus: A single hospital experience. Epilepsy & Behavior Reports 20, pages 100567.
Crossref
Crossref
Herlinda Bonilla-Jaime, Helena Zeleke, Asheebo Rojas & Claudia Espinosa-Garcia. (2021) Sleep Disruption Worsens Seizures: Neuroinflammation as a Potential Mechanistic Link. International Journal of Molecular Sciences 22:22, pages 12531.
Crossref
Crossref
Katarzyna Załuska-Ogryzek, Paweł Marzęda, Paula Wróblewska-Łuczka, Magdalena Florek-Łuszczki, Zbigniew Plewa, Hubert Bojar, Dorota Zolkowska & Jarogniew J. Łuszczki. (2021) Interactions among Lacosamide and Second-Generation Antiepileptic Drugs in the Tonic-Clonic Seizure Model in Mice. International Journal of Molecular Sciences 22:11, pages 5537.
Crossref
Crossref